206 related articles for article (PubMed ID: 34405013)
1. Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Gong YZ; Ma H; Ruan GT; Zhu LC; Liao XW; Wang S; Yan L; Huang W; Huang KT; Xie H; Zhu GZ; Wang XK; Liao C; Gao F
J Cancer; 2021; 12(18):5506-5518. PubMed ID: 34405013
[No Abstract] [Full Text] [Related]
2. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
[TBL] [Abstract][Full Text] [Related]
3. Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.
Ruan GT; Xie HL; Zhu LC; Ge YZ; Yan L; Liao C; Gong YZ; Shi HP
Front Genet; 2022; 13():762514. PubMed ID: 35211154
[No Abstract] [Full Text] [Related]
4. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
Front Genet; 2022; 13():821826. PubMed ID: 35664320
[No Abstract] [Full Text] [Related]
5. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
Miao YD; Kou ZY; Wang JT; Mi DH
World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
7. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
Front Genet; 2022; 13():816173. PubMed ID: 35281843
[No Abstract] [Full Text] [Related]
8. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.
Lin Y; Li Y; Chen Y; Zhang Z
Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164
[TBL] [Abstract][Full Text] [Related]
9. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive investigation of the prognostic values and molecular mechanisms of syntaxin binding protein 5 antisense RNA 1 in patients with colon adenocarcinoma based on RNA sequencing dataset.
Wei H; Tang L; Wang J; Ni M; Liao X; Guo E
J Cancer; 2023; 14(9):1607-1622. PubMed ID: 37325053
[No Abstract] [Full Text] [Related]
12. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.
Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P
Front Genet; 2023; 14():1098190. PubMed ID: 37274780
[No Abstract] [Full Text] [Related]
13. High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma.
Zhao P; Ning J; Huang J; Wei B; Wang Z; Huang X
Int J Gen Med; 2023; 16():4595-4615. PubMed ID: 37850194
[TBL] [Abstract][Full Text] [Related]
14. Identification prognosis-associated immune genes in colon adenocarcinoma.
Miao Y; Wang J; Ma X; Yang Y; Mi D
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
Wu M; Kim KY; Park WC; Ryu HS; Choi SC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
Transl Oncol; 2020 Dec; 13(12):100861. PubMed ID: 32891902
[TBL] [Abstract][Full Text] [Related]
16. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
17. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.
Huang X; Cao Y; Bao P; Zhu B; Cheng Z
Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma.
Zhang J; Liu Z; Chen W; Liu H
Transl Cancer Res; 2023 Sep; 12(9):2239-2255. PubMed ID: 37859737
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
20. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
Zhang C; Zhao Z; Liu H; Yao S; Zhao D
Front Genet; 2021; 12():657658. PubMed ID: 34322151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
